Literature DB >> 15650803

Long-term follow-up after adrenalectomy for primary aldosteronism.

Andreas Meyer1, Georg Brabant, Matthias Behrend.   

Abstract

The objective of this study was to assess the long-term effects of adrenalectomy on the blood pressure and antihypertensive medication in patients with primary aldosteronism (PA). Twenty-four patients (15 female and 9 male) with a mean age of 48.3 +/- 10.8 years underwent surgery for PA in our institution between 1988 and 2001. All subjects were re-examined with a complete clinical work-up after a mean follow-up period of 86 +/- 48 months, including blood pressure readings (<140/90 mmHg defined as normal), endocrine adrenal function, and specific medication. All patients suffered from hypertension (onset 8.5 +/- 5.5 years prior to surgery). In 92% of the patients, hypokalemia was present (onset 2.0 +/- 2.6 years prior to surgery). The histopathologic examinations revealed unilateral adenomas in 23 patients and a bilateral hyperplasia in one patient. At follow-up, 33% (8) of the patients were completely cured (normal blood pressure and no antihypertensive treatment), with seven of these eight patients being under 50 years of age at the time of surgery. One patient revealed a contralateral aldosterone-secreting adrenal adenoma during the subsequent endocrine and imaging examination 44 months after the first operation. Despite normalized plasma-aldosterone concentration (PAC), plasma-renin-activity (PRA) and serum potassium levels, a long-lasting insufficiently treated hypertension due to the delayed diagnosis in patients with PA may explain the persistent blood pressure elevation, indicating the necessity of a life-long, regular control of the blood pressure and antihypertensive medication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650803     DOI: 10.1007/s00268-004-7496-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  36 in total

1.  Cautions over the current epidemic of primary aldosteronism.

Authors:  N M Kaplan
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

2.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

3.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 4.  Diagnosis and treatment of primary aldosteronism.

Authors:  J D Blumenfeld; E D Vaughan
Journal:  World J Urol       Date:  1999-02       Impact factor: 4.226

5.  Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism.

Authors:  W T Shen; R C Lim; A E Siperstein; O H Clark; W P Schecter; T K Hunt; J K Horn; Q Y Duh
Journal:  Arch Surg       Date:  1999-06

6.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy.

Authors:  Yuji Fukudome; Koji Fujii; Hisatomi Arima; Yusuke Ohya; Takuya Tsuchihashi; Isao Abe; Masatoshi Fujishima
Journal:  Hypertens Res       Date:  2002-01       Impact factor: 3.872

Review 8.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

9.  Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

Authors:  C A Proye; E A Mulliez; B M Carnaille; M Lecomte-Houcke; M Decoulx; J L Wémeau; J Lefebvre; A Racadot; O Ernst; D Huglo; A Carré
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

10.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11
View more
  22 in total

1.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 2.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

3.  Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism.

Authors:  G A Kline; V C Dias; B So; A Harvey; J L Pasieka
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

Review 4.  Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.

Authors:  Gregory L Hundemer
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 5.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 6.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

7.  Adrenocortical causes of hypertension.

Authors:  Andreas Moraitis; Constantine Stratakis
Journal:  Int J Hypertens       Date:  2011-03-08       Impact factor: 2.420

8.  Predictors of successful outcome after adrenalectomy for primary aldosteronism.

Authors:  Wei Wang; WeiLie Hu; XiaoMing Zhang; BangQi Wang; Chen Bin; Hai Huang
Journal:  Int Surg       Date:  2012 Apr-Jun

9.  Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.

Authors:  J Hennings; S Andreasson; J Botling; A Hägg; A Sundin; P Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

Review 10.  Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.